Structural and functional neuroimaging studies in major depressive disorder with psychotic features: A critical review

Schizophrenia Bulletin

Volumn 39, Issue 4, 2013, Pages 776-786

  Busatto, Geraldo F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

depression; fMRI; magnetic resonance imaging; PET; psychosis

Indexed keywords

ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BIPOLAR DISORDER; BRAIN BLOOD FLOW; BRAIN SIZE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL THICKNESS (BRAIN); DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; INSULA; MAJOR DEPRESSION; MAJOR DEPRESSIVE DISORDER WITH PSYCHOTIC FEATURE; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNCINATE FASCICULUS; VOXEL BASED MORPHOMETRY; WHITE MATTER; WORKING MEMORY;

EID: 84879332423     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt054     Document Type: Article

References (123)

1. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry. 2006; 188: 510-518. (Pubitemid 43844097)
2. Busatto GF, Zanetti MZ, Schaufelberger MS, Crippa JAS. Brain Anatomical Abnormalities in Schizophrenia: Neurodevelopmental Origins and Patterns of Progression over Time. Vol 2. New York: Springer; 2010.
3. van Haren NE, Schnack HG, Cahn W, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry. 2011; 68: 871-880.
4. Bora E, Fornito A, Radua J, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise metaanalysis and meta-regression analysis. Schizophr Res. 2011; 127: 46-57.
5. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res. 2009; 108: 3-10.
6. Kawashima T, Nakamura M, Bouix S, et al. Uncinate fasciculus abnormalities in recent onset schizophrenia and affective psychosis: a diffusion tensor imaging study. Schizophr Res. 2009; 110: 119-126.
7. Walterfang M, Wood AG, Reutens DC, et al. Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis. Psychiatry Res. 2009; 173: 77-82.
8. Chaim TM, Schaufelberger MS, Ferreira LK, et al. Volume reduction of the corpus callosum and its relationship with deficits in interhemispheric transfer of information in recentonset psychosis. Psychiatry Res. 2010; 184: 1-9.
9. Lehrer DS, Christian BT, Mantil J, et al. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Am J Psychiatry. 2005; 162: 931-938. (Pubitemid 40676206)
10. Kühn S, Gallinat J. Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophr Bull. 2013; 39: 358-365.
11. Craddock N, O'Donovan MC, Owen MJ. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr Bull. 2009; 35: 482-490.
12. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry. 2009; 195: 194-201.
13. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res. 2010; 117: 1-12.
14. De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des. 2012; 18: 486-494.
15. McDonald C, Marshall N, Sham PC, et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry. 2006; 163: 478-487. (Pubitemid 44469391)
16. Watson DR, Anderson JM, Bai F, et al. A voxel based morphometry study investigating brain structural changes in first episode psychosis. Behav Brain Res. 2012; 227: 91-99.
17. Bora E, Fornito A, Yücel M, Pantelis C. The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. Psychol Med. 2011; 42: 295-307.
18. Lu LH, Zhou XJ, Keedy SK, Reilly JL, Sweeney JA. White matter microstructure in untreated first episode bipolar disorder with psychosis: comparison with schizophrenia. Bipolar Disord. 2011; 13: 604-613.
19. Whalley HC, Papmeyer M, Sprooten E, Lawrie SM, resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord. 2012; 14: 411-431.
20. Delvecchio G, Sugranyes G, Frangou S. Evidence of diagnostic specificity in the neural correlates of facial affect processing in bipolar disorder and schizophrenia: a metaanalysis of functional imaging studies. Psychol Med. 2012; 43: 553-569.
21. Keller J, Schatzberg AF, Maj M. Current issues in the classification of psychotic major depression. Schizophr Bull. 2007; 33: 877-885. (Pubitemid 47216665)
22. Crebbin K, Mitford E, Paxton R, Turkington D. Firstepisode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia. J Affect Disord. 2008; 105: 117-124. (Pubitemid 350236357)
23. Gaudiano BA, Dalrymple KL, Zimmerman M. Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic. Depress Anxiety. 2009; 26: 54-64.
24. Hill SK, Keshavan MS, Thase ME, Sweeney JA. Neuropsychological dysfunction in antipsychotic-naive firstepisode unipolar psychotic depression. Am J Psychiatry. 2004; 161: 996-1003. (Pubitemid 38735985)
25. Tohen M, Khalsa HM, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012; 136: 1-8.
26. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004; 161: 598-607. (Pubitemid 38445502)
27. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004; 161: 1957-1966. (Pubitemid 39441394)
28. Hajek T, Kozeny J, Kopecek M, Alda M, Höschl C. Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci. 2008; 33: 91-99. (Pubitemid 351441379)
29. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009; 30: 3719-3735.
30. Arnone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012; 22: 1-16.
31. Taki Y, Kinomura S, Awata S, et al. Male elderly subthreshold depression patients have smaller volume of medial part of prefrontal cortex and precentral gyrus compared with age-matched normal subjects: a voxel-based morphometry. J Affect Disord. 2005; 88: 313-320. (Pubitemid 41446973)
32. Cheng YQ, Xu J, Chai P, et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naïve first-episode MDD patients: a voxel-based morphometry study. Neurosci Lett. 2010; 480: 30-34.
33. Du MY, Wu QZ, Yue Q, et al. Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 36: 11-16.
34. Tu PC, Chen LF, Hsieh JC, Bai YM, Li CT, Su TP. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study. Psychiatry Res. 2012; 202: 206-213.
35. Soriano-Mas C, Hernández-Ribas R, Pujol J, et al. Crosssectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol Psychiatry. 2011; 69: 318-325.
36. Frodl T, Meisenzahl EM, Zetzsche T, et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry. 2002; 159: 1112-1118. (Pubitemid 34743250)
37. Arnone D, McKie S, Elliott R, et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry. 2012b.
38. Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience. 2009; 164: 300-330.
39. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000; 48: 830-843.
40. Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 2002; 12: 527-544. (Pubitemid 35408704)
41. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry. 2001; 58: 631-640. (Pubitemid 32640857)
42. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010; 35: 192-216.
43. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 1999; 45: 395-402. (Pubitemid 29130435)
44. Lodge DJ, Grace AA. Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci. 2011; 29: 207-213.
45. Palaniyappan L, Liddle PF. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci. 2012; 37: 17-27.
46. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry. 1988; 153: 437-443.
47. Arnone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012; 22: 1-16.
48. Wang PW, Ketter TA. Biology and recent brain imaging studies in affective psychoses. Curr Psychiatry Rep. 2000; 2: 298-304.
49. Zanetti MV, Schaufelberger MS, de Castro CC, et al. Whitematter hyperintensities in first-episode psychosis. Br J Psychiatry. 2008; 193: 25-30.
50. Sexton CE, Mackay CE, Ebmeier KP. A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry. 2009; 66: 814-823.
51. Rothschild AJ, Benes F, Hebben N, et al. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry. 1989; 26: 565-575. (Pubitemid 19244768)
52. Schlegel S, Kretzschmar K. Computed tomography in affective disorders. Part I. Ventricular and sulcal measurements. Biol Psychiatry. 1987; 22: 4-14. (Pubitemid 17229947)
53. Targum SD, Rosen LN, DeLisi LE, Weinberger DR, Citrin CM. Cerebral ventricular size in major depressive disorder: association with delusional symptoms. Biol Psychiatry. 1983; 18: 329-336. (Pubitemid 13112814)
54. Shiraishi H, Koizumi J, Hori M, et al. A computerized tomographic study in patients with delusional and non-delusional depression. Jpn J Psychiatry Neurol. 1992; 46: 99-105.
55. Luchins DJ, Meltzer HY. Ventricular size and psychosis in affective disorder. Biol Psychiatry. 1983; 18: 1197-1198.
56. Simpson S, Baldwin RC, Jackson A, Burns A. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol Psychiatry. 1999; 45: 193-204. (Pubitemid 29079450)
57. Salokangas RK, Cannon T, Van Erp T, et al. Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project. Br J Psychiatry Suppl. 2002; 43: s58-s65. (Pubitemid 34983514)
58. de Azevedo-Marques Périco C, Duran FL, Zanetti MV, et al. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects. Bipolar Disord. 2011; 13: 28-40.
59. Rosa PG, Schaufelberger MS, Uchida RR, et al. Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: a populationbased morphometric MRI study. World J Biol Psychiatry. 2010; 11: 873-887.
60. Keller J, Shen L, Gomez RG, et al. Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. Am J Psychiatry. 2008; 165: 872-880. (Pubitemid 351948719)
61. Vassilopoulou K, Papathanasiou M, Michopoulos I, et al. A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression. J Affect Disord. 2013; 146: 197-204.
62. Kim DK, Kim BL, Sohn SE, et al. Candidate neuroanatomic substrates of psychosis in old-aged depression. Prog Neuropsychopharmacol Biol Psychiatry. 1999; 23: 793-807. (Pubitemid 29416755)
63. Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry. 2005; 162: 1706-1712. (Pubitemid 41318241)
64. Skaf CR, Yamada A, Garrido GE, et al. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. J Affect Disord. 2002; 68: 295-305. (Pubitemid 34632667)
65. Nakamura M, Salisbury DF, Hirayasu Y, et al. Neocortical gray matter volume in first-episode schizophrenia and firstepisode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry. 2007; 62: 773-783. (Pubitemid 47374652)
66. Schaufelberger MS, Duran FL, Lappin JM, et al. Grey matter abnormalities in Brazilians with first-episode psychosis. Br J Psychiatry Suppl. 2007; 51: s117-s122. (Pubitemid 350273200)
67. Morgan KD, Dazzan P, Orr KG, et al. Grey matter abnormalities in first-episode schizophrenia and affective psychosis. Br J Psychiatry Suppl. 2007; 51: s111-s116. (Pubitemid 350273199)
68. Reig S, Parellada M, Castro-Fornieles J, et al. Multicenter study of brain volume abnormalities in children and adolescent- onset psychosis. Schizophr Bull. 2011; 37: 1270-1280.
69. El-Sayed M, Steen RG, Poe MD, et al. Brain volumes in psychotic youth with schizophrenia and mood disorders. J Psychiatry Neurosci. 2010; 35: 229-236.
70. de Castro-Manglano P, Mechelli A, Soutullo C, et al. Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome. Bipolar Disord. 2011; 13: 545-555.
71. Takahashi T, Wood SJ, Soulsby B, et al. An MRI study of the superior temporal subregions in first-episode patients with various psychotic disorders. Schizophr Res. 2009; 113: 158-166.
72. Bora E, Fornito A, Radua J, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res. 2011; 127: 46-57.
73. Hirayasu Y, Shenton ME, Salisbury DF, et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999; 156: 1091-1093. (Pubitemid 29302806)
74. Kubicki M, Shenton ME, Salisbury DF, et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage. 2002; 17: 1711-1719. (Pubitemid 36062762)
75. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry. 2008; 65: 746-760. (Pubitemid 351957701)
76. Kasai K, Shenton ME, Salisbury DF, et al. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry. 2003; 60: 1069-1077. (Pubitemid 37429646)
77. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 2008; 10: 1-37.
78. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 2001; 98: 4746-4751. (Pubitemid 32295047)
79. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry. 2006; 60: 132-140.
80. Walker RM, Christoforou A, Thomson PA, et al. Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci Lett. 2010; 478: 9-13.
81. Domschke K, Lawford B, Young R, et al. Dysbindin (DTNBP1)-a role in psychotic depression? J Psychiatr Res. 2011; 45: 588-595.
82. Weickert CS, Straub RE, McClintock BW, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry. 2004; 61: 544-555. (Pubitemid 38747309)
83. Marballi K, Cruz D, Thompson P, Walss-Bass C. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings. PLoS ONE. 2012; 7: e36431.
84. Pennington K, Dicker P, Dunn MJ, Cotter DR. Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics. 2008; 8: 5097-5107.
85. Martins-de-Souza D. Proteomics tackling schizophrenia as a pathway disorder. Schizophr Bull. 2012b; 38: 1107-1108.
86. McCormick LM, Boles Ponto LL, Pierson RK, Johnson HJ, Magnotta V, Brumm MC. Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy. J ECT. 2007; 23: 265-273. (Pubitemid 350307767)
87. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012; 69: 776-786.
88. Pearlson GD, Wong DF, Tune LE, et al. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry. 1995; 52: 471-477.
89. Reeves S, Brown R, Howard R, Grasby P. Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. Neurology. 2009; 72: 528-534.
90. Sapolsky RM, Krey LC, McEwen BS. Glucocorticoidsensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA. 1984; 81: 6174-6177. (Pubitemid 15220802)
91. Frodl T, O'Keane V. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol Dis. 2013; 52: 24-37.
92. Schatzberg AF, Posener JA, Rothschild AJ. The role of dopamine in psychotic depression. Clin Neuropharmacol. 1995; 18(Suppl 1): S66-S73.
93. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010; 214: 655-667.
94. Shepherd AM, Matheson SL, Laurens KR, Carr VJ, Green MJ. Systematic meta-analysis of insula volume in schizophrenia. Biol Psychiatry. 2012; 72: 775-784.
95. Takahashi T, Wood SJ, Soulsby B, et al. Diagnostic specificity of the insular cortex abnormalities in first-episode psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33: 651-657.
96. Takahashi T, Yücel M, Lorenzetti V, et al. Volumetric MRI study of the insular cortex in individuals with current and past major depression. J Affect Disord. 2010; 121: 231-238.
97. Sprengelmeyer R, Steele JD, Mwangi B, et al. The insular cortex and the neuroanatomy of major depression. J Affect Disord. 2011; 133: 120-127.
98. Garrett A, Kelly R, Gomez R, Keller J, Schatzberg AF, Reiss AL. Aberrant brain activation during a working memory task in psychotic major depression. Am J Psychiatry. 2011; 168: 173-182.
99. Martins-de-Souza D, Guest PC, Harris LW, et al. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl Psychiatry. 2012; 2: e87.
100. Corlett PR, Taylor JR, Wang XJ, Fletcher PC, Krystal JH. Toward a neurobiology of delusions. Prog Neurobiol. 2010; 92: 345-369.
101. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L. Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry. 2007; 68: 1411-1417. (Pubitemid 47524522)
102. Sun J, Maller JJ, Guo L, Fitzgerald PB. Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies. Brain Res Rev. 2009; 61: 14-32.
103. Baethge C, Baldessarini RJ, Freudenthal K, Streeruwitz A, Bauer M, Bschor T. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord. 2005; 7: 136-145. (Pubitemid 40439473)
104. Jardri R, Pouchet A, Pins D, Thomas P. Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry. 2011; 168: 73-81.
105. Kelley R, Garrett A, Cohen J, et al. Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Res. 2013; 211: 119-126.
106. Sommer IE, Vd Veer AJ, Wijkstra J, Boks MP, Kahn RS. Comparing language lateralization in psychotic mania and psychotic depression to schizophrenia; a functional MRI study. Schizophr Res. 2007; 89: 364-365. (Pubitemid 44881310)
107. van Veelen NM, Vink M, Ramsey NF, et al. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophr Res. 2011; 127: 195-201.
108. Anticevic A, Brumbaugh MS, Winkler AM, et al. Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry. 2013; 73: 565-573.
109. Dudek D, Siwek M, Zielińska D, Jaeschke R, Rybakowski J. Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review. J Affect Disord. 2013; 144: 112-115.
110. Ruggero CJ, Kotov R, Carlson GA, Tanenberg-Karant M, González DA, Bromet EJ. Diagnostic consistency of major depression with psychosis across 10 years. J Clin Psychiatry. 2011; 72: 1207-1213.
111. Tohen M, Khalsa HM, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012; 136: 1-8.
112. Bromet EJ, Kotov R, Fochtmann LJ, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry. 2011; 168: 1186-1194.
113. Whitty P, Clarke M, McTigue O, et al. Diagnostic stability four years after a first episode of psychosis. Psychiatr Serv. 2005; 56: 1084-1088. (Pubitemid 41266835)
114. Peralta V, Cuesta MJ. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. J Affect Disord. 2008; 108: 71-86. (Pubitemid 351418016)
115. Majadas S, Olivares J, Galan J, Diez T. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Compr Psychiatry. 2012; 53: 145-151.
116. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011; 68: 128-137.
117. Smith R, Chen K, Baxter L, Fort C, Lane RD. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J Affect Disord. 2013; 146: 414-419.
118. Hasler G, Northoff G. Discovering imaging endophenotypes for major depression. Mol Psychiatry. 2011; 16: 604-619.
119. Cannon DM, Walshe M, Dempster E, et al. The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives. Transl Psychiatry. 2012; 2: e167.
120. Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, et al. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry. 2013; 73: 525-531.
121. Whalley HC, Papmeyer M, Sprooten E, et al. The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI. Transl Psychiatry. 2012; 2: e130.
122. Modinos G, Pettersson-Yeo W, Allen P, McGuire PK, Aleman A, Mechelli A. Multivariate pattern classification reveals differential brain activation during emotional processing in individuals with psychosis proneness. Neuroimage. 2012; 59: 3033-3041.
123. Maj M. Delusions in major depressive disorder: recommendations for the DSM-V. Psychopathology. 2008; 41: 1-3. (Pubitemid 350146906)